Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Future Science Group

We are an expanding group of independent publishing companies active in the field of scientific information and endeavor, currently composed of Expert Reviews, Future Medicine and Future Science. As a leading provider of products and services for the medical, scientific and business communities, we save customers time and money by presenting the most important scientific breakthroughs in an accessible and evaluated format, while at the same time providing the scientific community with unique vehicles for disseminating forward-thinking research information and data.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Springer Nature

Springer Nature

Did you know that we publish over 3,000 journals, and that over 1,000 of those are clinical science journals? Promote your approved branded drugs and medical devices to our audience…

View Profile

Advertising, Medical communications, Publishers

Streaming Well - Video For Healthcare

Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual stories and interactive experiences that connect with people.

View Profile

Advertising, Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Medical communications, Medical education, Publishers, Translation services

- PMLiVE

Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that we attend each year.

View Profile

Medical communications, Medical education, Publishers

Company Details

Future Science Group
Unitec House, 1 Albert Place, Finchley, London, N3 1QB, United Kingdom
+44 (0)20 8371 4051
Contact Future Science Group
Website

 Latest Content from PMHub 

A stumble, but not a fall – what’s next for Opdivo?

White Papers and Resources | August 25, 2016 | Blue Latitude Health

Blue Latitude Health's Louis Perdios talks about the daunting challenges faced by BMS after Opdivo's disappointing results.

Meet Anthill at conferences in London

White Papers and Resources | August 19, 2016 | Anthill Agency

October, the month of multichannel pharma marketing in London. Meet us at DigiPharm and Multichannel Excellence Summit

Immuno-oncology; bringing patients closer to treatment

White Papers and Resources | August 18, 2016 | Blue Latitude Health

What do the new immunotherapies in oncology mean for those stakeholders who need to understand and make decisions about treatment?

Therapy Watch market snapshots

White Papers and Resources | August 12, 2016 | Inizio

Therapy Watch is a ‘real-time’ syndicated market tracking tool that provides marketing teams, brand managers and market researchers with strategic and tactical market information. Run entirely online to ensure speed,...

Case Study: Private market opportunity for a travel vaccine

White Papers and Resources | August 12, 2016 | Inizio

Our client needed exploratory research to determine the global opportunity for a new travel vaccine in the private market. It was crucial to determine:Which markets had the highest potential to...

Infographic: Conference Live

White Papers and Resources | August 12, 2016 | Inizio

Conference Live gives you real-time insights, utilising the multimedia functionality of the smartphone in an innovative mobile app methodology. We conduct mobile conference research amongst physicians attending conferences, giving our clients...

Blog: The Cost of Counterfeits

White Papers and Resources | August 12, 2016 | Inizio

The sale of counterfeit drugs is growing at twice the rate of legitimate pharmaceuticals and pharma companies stand to lose more than just profits from the fallout of counterfeit identification.

Video: Self-pay and Emerging Markets

White Papers and Resources | August 12, 2016 | Inizio

A key feature of emerging markets is that patients often have to pay for a high proportion of their healthcare costs themselves. For all but the most severe conditions, public...

News: Therapy Watch HCV expands into 4 additional EU markets

White Papers and Resources | August 12, 2016 | Inizio

The HCV market has been growing and changing remarkably quickly and with the development of new and improving drugs, the treatment of HCV has moved on in a short space...

News: Research Partnership launches new patient report – Living with Ulcerative Colitis

White Papers and Resources | August 12, 2016 | Inizio

Living with UC is a quantitative study conducted online amongst 325 patients, including both adult and paediatric patients diagnosed with ulcerative colitis in 5 EU markets (France, Germany, Italy, Spain...